查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2017148

外科黏合剂市场：按产品类型、配方、应用和最终用户划分 - 全球市场预测 2026-2032

Surgical Glue Market by Product Type, Formulation, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，外科黏合剂市场价值将达到 24.4 亿美元，到 2026 年将成长至 25.9 亿美元，到 2032 年将达到 36.9 亿美元，复合年增长率为 6.05%。

主要市场统计数据
基准年 2025 24.4亿美元
预计年份：2026年 25.9亿美元
预测年份 2032 36.9亿美元
复合年增长率 (%) 6.05%

对现代外科黏合剂技术、监管变化和临床期望如何重新定义手术全期黏合策略的权威说明。

外科黏合剂领域已从单纯的伤口缝合辅助工具发展成为现代围手术全期策略的核心多功能工具。临床医生现在不仅将这些产品视为止血剂或封闭剂，更将其视为实现微创手术、简化手术流程以及减少对精细解剖结构缝线依赖的工具。配方技术和给药系统的进步已将临床应用范围扩展到特定专科之外，并加速了医院委员会、门诊中心和诊所对采购政策和临床路径的审查。

材料创新、先进的剂量平台和不断变化的监管重点如何共同加速外科黏合剂的普及并重新定义其标准。

外科黏合剂领域的变革是材料科学、递送工程和临床实践等多面向因素共同作用的结果，这些因素共同重新定义了黏合剂和组织路径的预期。黏合剂的化学改进使其功能不仅限于密封；它们还能与组织微环境相互作用，促进癒合，同时最大限度地减少发炎反应。同时，合成平台正日益提供客製化的降解特性和可调控的机械性能，使临床医生能够根据组织的动态来调整黏合剂的性能，从血管修復到眼科果冻，均可应用。

评估近期关税变化对外科黏合剂整个价值链的供应链、采购趋势和创新计画的连锁反应。

对医疗设备进口征收关税正对外科黏合剂生态系统产生复杂且连锁的影响，尤其体现在供应链、成本和采购管道等。关税推高了依赖跨国生产的零件和成品的到岸成本，促使製造商重新评估其筹资策略和供应商合约。为此，许多公司正在加强近岸外包和双重采购，以降低贸易政策波动带来的风险。同时，一些公司正在加快关键合成和配方流程的在地化进程，以保持价格竞争力，满足医院采购团队的需求。

深入的細項分析，将产品化学特性、配方、临床应用和最终用户优先顺序与外科手术环境中的实际实施途径相结合。

详细的细分观点揭示了不同产品类型、配方、临床应用和终端用户环境在性能和实施动态方面的差异。每种产品都有其独特的操作和临床优先事项。基于产品类型，以白蛋白和纤维蛋白胶为特征的黏合剂往往优先考虑生物相容性和固有的止血性能，因此更适用于易出血组织或血管丰富的组织。另一方面，氰基丙烯酸酯和聚乙二醇水凝胶等合成黏合剂则优先考虑可预测的机械强度、可控的降解性和高效的生产可扩展性。临床医生通常会在比较组织相容性、操作特性和储存稳定性后，选择具有这些化学特性的产品。

透过跨区域的比较分析，可以揭示美洲、欧洲、中东和非洲以及亚太地区的趋势如何影响监管参与、采购和临床引入途径。

区域趋势正以不同的方式影响外科黏合剂的引进途径、监管参与和分销策略。在美洲，先进的医院系统和不断扩展的门诊服务推动了对能够提高手术效率和微创手术的黏合剂的需求。同时，监管机构和健保体系越来越重视能够证明併发症减少和手术能力提升的证据。这使得临床数据的可靠性、外科培训计画和供应链的可靠性成为商业性成功的关键。

竞争情报和商业情报重点分析了产品差异化、实证应用和供应链韧性如何决定外科黏合剂产业的领导地位。

外科黏合剂产业的竞争动态主要体现在产品差异化、实证医学证据的累积以及透过培训和稳定的供应来支持临床应用的能力。主要企业倾向于投资转化研究，将实验室表现与可验证的临床结果联繫起来，从而更清楚地向医院董事会和外科负责人传达讯息。那些透过施用器系统、临床医生培训计画和完善的上市后监测来完善产品系列的公司，能够透过关键意见领袖 (KOL) 和医疗保健采购人员获得更强劲的市场需求。

为製造商和医疗保健采购经理提供实用的策略指导，以协调创新、供应弹性和商业模式，从而加速临床部署。

产业领导者应采取协调一致的策略，将研发、监管合规规划和商业性执行有机结合，以加速产品应用并降低供应风险。应优先开发可跨应用模组化的平台技术。旨在满足高精度显微外科手术和更广泛的普通外科手术应用需求的产品，将提升产品生命週期价值并简化培训流程。这些技术设计应辅以强有力的、具有临床意义的证据计划，重点是与采购委员会相关的成果，例如减少併发症和简化工作流程。

采用稳健的混合方法研究途径，结合对临床医生的访谈、对监管指南的审查以及对证据的三角检验，可以产生可操作的行业见解。

本研究采用混合方法进行综合分析，结合了原始质性资料和严格的二次检验，确保研究结果具有临床基础和实际可行性。原始研究包括对各专科的执业外科医生、门诊中心和医院的采购经理以及监管和临床运营方面的高级专家进行结构化访谈。这些访谈提供了超越实验室性能数据的背景信息，重点关注实际操作特性、处方决策标准以及有助于推广应用的临床终点。

对临床创新、监管预期和供应韧性如何全面决定长期应用和策略定位进行明确的整合。

外科黏合剂正日趋成熟，成为超越简单止血的策略性临床工具，在工作流程优化、医疗设备相容性以及改善病患预后等领域展现出价值。生物基和合成化学的持续进步，以及配方和给药方法的创新，为临床医生提供了一套更全面的工具，以满足各种手术不同的机械和生物学需求。同时，采购和法规环境也日益注重结果导向，要求供应商证明其产品在实际临床应用中的效果和营运效益。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 外科黏合剂市场：依产品类型划分

  • 黏合剂
    • 白蛋白
    • 纤维蛋白胶
  • 合成黏合剂
    • 氰基丙烯酸酯
    • 聚乙二醇水凝胶

第九章：黏合剂

  • 液体
    • 双组分型
    • 单组分类型
  • 修补
    • 自然补丁
    • 合成贴片
  • 喷
    • 气雾剂
    • 喷射

第十章 外科黏合剂市场：依应用领域划分

  • 心血管外科
    • 心臟瓣膜置换术
    • 血管修復
  • 牙科
  • 一般外科
    • 腹部手术
    • 胸腔外科
  • 眼科手术
  • 整形外科手术
    • 骨固定
    • 关节修復

第十一章 外科黏合剂市场：依最终用户划分

  • 门诊手术中心
    • 由医院直接营运的门诊手术中心
    • 独立ASC
  • 诊所
    • 门诊部
    • 专科诊所
  • 医院
    • 私立医院
    • 公立医院

第十二章 外科黏合剂市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章黏合剂市场：按类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 外科黏合剂市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国外科黏合剂市场

第十六章：中国外科黏合剂市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3M Company
  • Adhezion Biomedical, LLC
  • B. Braun Melsungen AG
  • Baxter International Inc
  • Becton Dickinson & Co.
  • Cohera Medical, Inc.
  • CryoLife, Inc.
  • Ethicon, Inc.
  • Integra LifeSciences Corporation
  • Medtronic plc
  • Smith & Nephew plc
Product Code: MRR-0355054AC4C4

The Surgical Glue Market was valued at USD 2.44 billion in 2025 and is projected to grow to USD 2.59 billion in 2026, with a CAGR of 6.05%, reaching USD 3.69 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.44 billion
Estimated Year [2026] USD 2.59 billion
Forecast Year [2032] USD 3.69 billion
CAGR (%) 6.05%

An authoritative orientation to how contemporary surgical glue technologies, regulatory shifts, and clinical expectations are redefining perioperative adhesion strategies

The landscape of surgical adhesives has evolved from simple wound closure adjuncts to multifunctional tools central to modern perioperative strategy. Clinicians now view these products not merely as hemostatic or sealing agents but as enablers of minimally invasive approaches, faster throughput, and reduced reliance on sutures in delicate anatomies. Advances in formulation technology and delivery systems have expanded clinical applicability across specialties, prompting hospital committees, ambulatory centers, and clinics to reassess procurement and clinical pathways.

Concurrently, regulatory frameworks and reimbursement considerations have adjusted to reflect the differentiated clinical value of biologic versus synthetic chemistries and to accommodate novel device-drug combination formats. This intersection of clinical innovation and policy evolution places supplier strategy and product development at the forefront of institutional decision-making. As a result, stakeholders from clinical leaders to supply chain managers demand clearer evidence of comparative performance, ease of use in diverse operative environments, and compatibility with existing workflows.

Looking forward, the sector's trajectory will be defined by how manufacturers balance biofunctionality with operational practicality. Innovations that meaningfully reduce procedure time, lower complication rates, or enable new minimally invasive techniques will influence clinical adoption. Strategic alignment between clinical evidence generation, regulatory positioning, and on-the-ground usability will determine which products establish durable preference within surgical protocols.

How materials breakthroughs, refined delivery platforms, and evolving regulatory focus are collectively accelerating adoption and redefining standards for surgical adhesives

The transformation of the surgical adhesive landscape reflects converging forces in materials science, delivery engineering, and clinical practice that collectively redefine expectations for hemostasis and tissue approximation. Improvements in bioadhesive chemistries have enabled adhesives to do more than seal; they now interact with tissue microenvironments to support healing while minimizing inflammatory response. At the same time, synthetic platforms increasingly offer tailored degradation profiles and tunable mechanical properties, allowing clinicians to match adhesive performance with tissue biomechanics in applications ranging from vascular repair to ophthalmic microsurgery.

Delivery innovations have been equally pivotal. The proliferation of single-component liquids, dual-component systems that mix at point of application, and advanced patch technologies provide clinicians with options that align with procedural complexity and access constraints. Aerosol and jet spray modalities extend the utility of adhesives to minimally invasive settings where precision and low-volume application matter. These shifts have also stimulated cross-disciplinary adoption: adhesives once confined to general surgery now feature in cardiovascular, orthopedic, dental, and ophthalmic practices because they can reduce operative time and improve handling in complex anatomies.

Regulatory and payer landscapes have responded by emphasizing clinically meaningful endpoints, such as reduction of postoperative complications and improvements in procedural efficiency, rather than focusing solely on bench metrics. Consequently, manufacturers are prioritizing robust clinical pathways and real-world evidence collection. Taken together, these technological and systemic changes are not incremental; they are enabling new standards of care that hinge on adhesive selection, integration into surgical workflows, and demonstrable patient benefit.

Assessing the ripple effects of recent tariff changes on supply chains, procurement dynamics, and innovation planning across the surgical adhesive value chain

The introduction of tariff measures targeting medical device imports has complex, cascading implications for the surgical adhesives ecosystem, most notably through supply chain, cost, and procurement pathways. Tariffs elevate landed costs for components and finished goods that rely on cross-border manufacturing, prompting manufacturers to reassess sourcing strategies and supplier agreements. In response, many companies intensify nearshoring or dual-sourcing efforts to mitigate exposure to trade policy volatility, while others accelerate localization of critical synthesis and formulation steps to preserve price competitiveness for hospital procurement teams.

Beyond direct cost effects, tariffs complicate purchasing decisions within health systems that operate under constrained budgets and fixed reimbursement schedules. Procurement executives face tougher trade-offs when evaluating branded biologic adhesives versus lower-cost synthetic alternatives, and they increasingly demand transparent total-cost-of-care analyses that account for acquisition price, procedure time savings, complication avoidance, and postacute resource utilization. Because tariffs can shift vendor negotiation dynamics, suppliers that maintain flexible distribution strategies and long-term contracts with integrated logistics partners gain a comparative advantage in sustaining supply continuity and predictable pricing.

Operationally, tariffs also influence innovation planning. Firms contemplating capital investments in new manufacturing lines or formulation upgrades must factor in tariff-induced cost volatility when modeling expected returns and pricing strategies. This dynamic accelerates collaboration between R&D, manufacturing, and commercial teams to prioritize technologies that are less supply-chain sensitive or that can be produced domestically. In sum, tariffs function as a forcing mechanism that reshapes supply chain architecture, procurement negotiations, and long-term investment decisions across the surgical adhesive sector.

Insightful segmentation analysis that maps product chemistries, formulations, clinical applications, and end-user priorities to practical adoption pathways across surgical settings

A granular segmentation lens reveals distinct performance and adoption dynamics across product categories, formulations, clinical applications, and end-user settings, each with its own operational and clinical priorities. Based on product type, biologic adhesives-characterized by albumin and fibrin sealant variants-tend to emphasize biocompatibility and intrinsic hemostatic activity, making them preferred in bleeding-prone or highly vascularized tissues, whereas synthetic adhesives such as cyanoacrylate and polyethylene glycol hydrogel prioritize predictable mechanical strength, controllable degradation, and streamlined manufacturing scalability. Clinicians often choose between these chemistries by weighing tissue compatibility against handling characteristics and storage stability.

Formulation differences further stratify clinical utility. Liquid formats are available as both dual-component systems that mix at the point of delivery and single-component preparations with simplified handling; patch technologies offer natural and synthetic substrates that provide mechanical support in addition to adhesion; and spray delivery, whether aerosol spray or jet spray, caters to surface coverage and minimally invasive access where precise placement and uniform distribution matter. Each formulation influences operating-room workflow, training needs, and device compatibility with adjunctive tools such as applicators or endoscopic ports.

Application-specific trends demonstrate how adhesive choice aligns with surgical objectives. In cardiovascular procedures, including heart valve replacement and vascular repair, adhesives must balance seal integrity with blood-contact compatibility, while in dental and ophthalmic contexts, microprecision and low-contact toxicity are paramount. General surgery applications such as abdominal and thoracic procedures require adhesives that perform across varied tissue types and that tolerate dynamic mechanical environments. Orthopedic indications like bone fixation and joint repair demand products with structural reinforcement potential and integration with fixation hardware.

End-user segmentation underscores divergent procurement drivers. Ambulatory surgical centers, whether hospital owned or independent, prioritize fast-setting, easy-to-use formulations that support high throughput. Clinics, both outpatient and specialty, seek adhesives with minimal infrastructure demands and clear storage profiles. Hospitals, whether private or public, evaluate adhesives through the lenses of formulary processes, clinical committee endorsement, and compatibility with institutional protocols. Together, these segmentation dimensions inform product development, evidence generation strategies, and commercialization approaches tailored to real-world practice.

Comparative regional intelligence revealing how Americas, Europe Middle East & Africa, and Asia-Pacific dynamics shape regulatory engagement, procurement, and clinical adoption pathways

Regional dynamics influence adoption pathways, regulatory engagement, and distribution strategies for surgical adhesives in distinct ways. In the Americas, advanced hospital systems and ambulatory care growth drive demand for adhesives that support efficiency gains and minimally invasive procedures, while regulatory agencies and reimbursement mechanisms increasingly favor evidence that demonstrates reductions in complications and improved procedural throughput. This creates a landscape where clinical data, surgeon training programs, and supply chain reliability are central to commercial success.

Across Europe, the Middle East & Africa, regulatory harmonization and varying procurement models produce a mosaic of adoption patterns. High-income markets within this region prioritize clinical outcomes and interoperability with established surgical workflows, whereas emerging healthcare systems emphasize cost-effectiveness and supply continuity. Manufacturers must navigate diverse regulatory pathways and tailor engagement strategies to local clinical opinion leaders, while also considering logistics and cold-chain requirements for biologic chemistries.

In Asia-Pacific, heterogeneous healthcare infrastructures and rapid expansion of surgical capacity create opportunities for both premium and cost-efficient adhesive technologies. The region's large procedural volumes and investment in minimally invasive surgery favor scalable synthetic platforms and localized manufacturing partnerships. At the same time, regulatory agencies increasingly require robust clinical evidence, prompting suppliers to invest in region-specific trials and post-market surveillance initiatives. These regional distinctions shape go-to-market models, allocation of commercial resources, and clinical evidence strategies for firms operating globally.

Competitive and operational intelligence highlighting how product differentiation, evidence-driven adoption, and supply chain resilience determine leadership in the surgical adhesive sector

Competitive dynamics in the surgical adhesive sector center on product differentiation, evidence generation, and the ability to support clinical adoption through training and supply reliability. Leading innovators tend to invest in translational research that connects bench performance with demonstrable clinical outcomes, enabling clearer messaging to hospital committees and surgical leaders. Companies that complement product portfolios with applicator systems, clinician training programs, and robust post-market surveillance create stronger pull through key opinion leaders and institutional buyers.

Strategic partnerships and licensing arrangements play a prominent role in accelerating time-to-clinic and expanding distribution reach. Firms that leverage distributor networks or form alliances with device manufacturers for co-developed delivery platforms often achieve broader trial access and faster uptake in specialty areas such as cardiovascular and ophthalmic surgery. Moreover, organizations that align clinical affairs, regulatory, and commercial teams to generate pragmatic evidence-such as comparative device studies and real-world performance metrics-tend to shorten the adoption curve.

Operational excellence in manufacturing and supply chain management differentiates companies under pressure from procurement stakeholders. Those that demonstrate consistent lead times, quality systems compliance, and flexible production capacity are more likely to be selected for long-term contracts by hospitals and ambulatory centers. Finally, a clear focus on cost-to-use and total procedural impact rather than acquisition price alone increasingly determines which companies sustain preferred status in formularies and long-term supplier lists.

Actionable strategic guidance for manufacturers and healthcare procurement leaders to align innovation, supply resilience, and commercial models for accelerated clinical adoption

Industry leaders should pursue a coordinated strategy that aligns R&D, regulatory planning, and commercial execution to accelerate adoption and mitigate supply risks. First, prioritize development of platform technologies that offer modularity across applications; products designed to serve both high-precision microsurgical needs and broader general surgery indications deliver greater lifecycle value and streamline training. Complement these technical designs with robust, clinically meaningful evidence plans that emphasize outcomes relevant to procurement committees, such as complication reduction and workflow efficiency.

Second, strengthen supply chain resilience through geographically diversified manufacturing and strategic supplier partnerships. Nearshoring critical synthesis steps and qualifying multiple raw-material sources will reduce exposure to tariff-induced cost swings and logistics disruptions. Concurrently, invest in standardized applicators and training modules that reduce variability in user technique and accelerate institutional credentialing, thereby shortening the conversion timeline from trial to formulary inclusion.

Third, tailor commercialization tactics to end-user priorities. For ambulatory surgical centers and outpatient clinics, emphasize ease of use, storage simplicity, and procedural throughput; for hospitals, focus on integration with clinical pathways, formulary processes, and long-term value assessments. Finally, implement outcome-oriented commercial models, such as bundled purchasing agreements or pilot programs with shared performance metrics, to reduce adoption friction and create measurable proof points that can be scaled across health systems.

Robust mixed-methods research approach combining clinician interviews, regulatory guidance review, and evidence triangulation to produce actionable sector intelligence

The research synthesis relies on a mixed-methods approach that integrates primary qualitative inputs with rigorous secondary validation to ensure findings are both clinically grounded and operationally actionable. Primary research included structured interviews with practicing surgeons across specialties, procurement leaders from ambulatory centers and hospitals, and senior regulatory and clinical affairs professionals. These conversations focused on real-world handling characteristics, formulary decision criteria, and clinical endpoints that drive adoption, providing context beyond bench performance data.

Secondary validation encompassed a comprehensive review of peer-reviewed clinical literature, relevant regulatory guidance documents, and clinical trial registries to corroborate performance narratives and safety profiles. Where applicable, procedural guidelines and consensus statements were examined to align product claims with accepted clinical best practices. Data triangulation ensured that anecdotal insights from interviews were supported by published evidence or consistent practice patterns observed across multiple geographies.

Analytical rigor was maintained through cross-functional peer review involving clinical, regulatory, and commercial subject-matter experts. Segmentation mapping was used to align product attributes with clinical and end-user requirements, and sensitivity checks were applied to interpret tariff and supply chain scenarios. This methodology delivered a contextualized evidence base intended to support strategic decision-making without relying on single-source assertions.

Conclusive synthesis of how clinical innovation, regulatory expectations, and supply resilience collectively determine long-term adoption and strategic positioning

Surgical adhesives are maturing into strategic clinical tools whose value extends beyond simple hemostasis to encompass workflow optimization, device compatibility, and patient outcome improvement. The ongoing refinement of biologic and synthetic chemistries, coupled with innovations in formulation and delivery, offers clinicians a broader toolkit tuned to the mechanical and biological requirements of diverse procedures. Meanwhile, procurement and regulatory environments are increasingly outcome-focused, compelling suppliers to demonstrate real-world impact and operational advantages.

Supply chain realities and policy shifts underscore the importance of resilient manufacturing strategies and flexible commercialization models. Organizations that proactively align clinical evidence generation with operational reliability and tailored go-to-market approaches are best positioned to influence clinical protocols and secure long-term procurement commitments. In conclusion, durable success in this sector requires a holistic approach that integrates science, clinical utility, and pragmatic commercial execution-anchored by evidence and reinforced by supply continuity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Glue Market, by Product Type

  • 8.1. Biological Adhesive
    • 8.1.1. Albumin
    • 8.1.2. Fibrin Sealant
  • 8.2. Synthetic Adhesive
    • 8.2.1. Cyanoacrylate
    • 8.2.2. Polyethylene Glycol Hydrogel

9. Surgical Glue Market, by Formulation

  • 9.1. Liquid
    • 9.1.1. Dual Component
    • 9.1.2. Single Component
  • 9.2. Patch
    • 9.2.1. Natural Patch
    • 9.2.2. Synthetic Patch
  • 9.3. Spray
    • 9.3.1. Aerosol Spray
    • 9.3.2. Jet Spray

10. Surgical Glue Market, by Application

  • 10.1. Cardiovascular Surgery
    • 10.1.1. Heart Valve Replacement
    • 10.1.2. Vascular Repair
  • 10.2. Dental
  • 10.3. General Surgery
    • 10.3.1. Abdominal Procedures
    • 10.3.2. Thoracic Procedures
  • 10.4. Ophthalmic Surgery
  • 10.5. Orthopedic Surgery
    • 10.5.1. Bone Fixation
    • 10.5.2. Joint Repair

11. Surgical Glue Market, by End User

  • 11.1. Ambulatory Surgical Center
    • 11.1.1. Hospital Owned ASC
    • 11.1.2. Independent ASC
  • 11.2. Clinic
    • 11.2.1. Outpatient Clinic
    • 11.2.2. Specialty Clinic
  • 11.3. Hospital
    • 11.3.1. Private Hospital
    • 11.3.2. Public Hospital

12. Surgical Glue Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Surgical Glue Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Surgical Glue Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Surgical Glue Market

16. China Surgical Glue Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. 3M Company
  • 17.6. Adhezion Biomedical, LLC
  • 17.7. B. Braun Melsungen AG
  • 17.8. Baxter International Inc
  • 17.9. Becton Dickinson & Co.
  • 17.10. Cohera Medical, Inc.
  • 17.11. CryoLife, Inc.
  • 17.12. Ethicon, Inc.
  • 17.13. Integra LifeSciences Corporation
  • 17.14. Medtronic plc
  • 17.15. Smith & Nephew plc

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL GLUE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL GLUE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SURGICAL GLUE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SURGICAL GLUE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL GLUE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SURGICAL GLUE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES SURGICAL GLUE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA SURGICAL GLUE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SURGICAL GLUE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL GLUE MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL GLUE MARKET SIZE, BY ALBUMIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL GLUE MARKET SIZE, BY ALBUMIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL GLUE MARKET SIZE, BY FIBRIN SEALANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL GLUE MARKET SIZE, BY FIBRIN SEALANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL GLUE MARKET SIZE, BY FIBRIN SEALANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL GLUE MARKET SIZE, BY CYANOACRYLATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL GLUE MARKET SIZE, BY CYANOACRYLATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL GLUE MARKET SIZE, BY CYANOACRYLATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL GLUE MARKET SIZE, BY POLYETHYLENE GLYCOL HYDROGEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL GLUE MARKET SIZE, BY POLYETHYLENE GLYCOL HYDROGEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL GLUE MARKET SIZE, BY POLYETHYLENE GLYCOL HYDROGEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL GLUE MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL GLUE MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL GLUE MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL GLUE MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL GLUE MARKET SIZE, BY DUAL COMPONENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL GLUE MARKET SIZE, BY DUAL COMPONENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL GLUE MARKET SIZE, BY DUAL COMPONENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL GLUE MARKET SIZE, BY SINGLE COMPONENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL GLUE MARKET SIZE, BY SINGLE COMPONENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL GLUE MARKET SIZE, BY SINGLE COMPONENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL GLUE MARKET SIZE, BY PATCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL GLUE MARKET SIZE, BY PATCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL GLUE MARKET SIZE, BY PATCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL GLUE MARKET SIZE, BY PATCH, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL GLUE MARKET SIZE, BY NATURAL PATCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL GLUE MARKET SIZE, BY NATURAL PATCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL GLUE MARKET SIZE, BY NATURAL PATCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC PATCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC PATCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL GLUE MARKET SIZE, BY SYNTHETIC PATCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL GLUE MARKET SIZE, BY AEROSOL SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL GLUE MARKET SIZE, BY AEROSOL SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL GLUE MARKET SIZE, BY AEROSOL SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL GLUE MARKET SIZE, BY JET SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL GLUE MARKET SIZE, BY JET SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL GLUE MARKET SIZE, BY JET SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL GLUE MARKET SIZE, BY HEART VALVE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL GLUE MARKET SIZE, BY HEART VALVE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL GLUE MARKET SIZE, BY HEART VALVE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL GLUE MARKET SIZE, BY VASCULAR REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL GLUE MARKET SIZE, BY VASCULAR REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL GLUE MARKET SIZE, BY VASCULAR REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL GLUE MARKET SIZE, BY DENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL GLUE MARKET SIZE, BY DENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL GLUE MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL GLUE MARKET SIZE, BY ABDOMINAL PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL GLUE MARKET SIZE, BY ABDOMINAL PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL GLUE MARKET SIZE, BY ABDOMINAL PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL GLUE MARKET SIZE, BY THORACIC PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL GLUE MARKET SIZE, BY THORACIC PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL GLUE MARKET SIZE, BY THORACIC PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL GLUE MARKET SIZE, BY OPHTHALMIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURGICAL GLUE MARKET SIZE, BY OPHTHALMIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SURGICAL GLUE MARKET SIZE, BY OPHTHALMIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SURGICAL GLUE MARKET SIZE, BY BONE FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SURGICAL GLUE MARKET SIZE, BY BONE FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SURGICAL GLUE MARKET SIZE, BY BONE FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SURGICAL GLUE MARKET SIZE, BY JOINT REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL GLUE MARKET SIZE, BY JOINT REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SURGICAL GLUE MARKET SIZE, BY JOINT REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SURGICAL GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL OWNED ASC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL OWNED ASC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL OWNED ASC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL SURGICAL GLUE MARKET SIZE, BY INDEPENDENT ASC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL SURGICAL GLUE MARKET SIZE, BY INDEPENDENT ASC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL SURGICAL GLUE MARKET SIZE, BY INDEPENDENT ASC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL SURGICAL GLUE MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL SURGICAL GLUE MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL SURGICAL GLUE MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL SURGICAL GLUE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL SURGICAL GLUE MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL SURGICAL GLUE MARKET SIZE, BY OUTPATIENT CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL SURGICAL GLUE MARKET SIZE, BY OUTPATIENT CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL SURGICAL GLUE MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL SURGICAL GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL SURGICAL GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL SURGICAL GLUE MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL SURGICAL GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL SURGICAL GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL SURGICAL GLUE MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL SURGICAL GLUE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS SURGICAL GLUE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS SURGICAL GLUE MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS SURGICAL GLUE MARKET SIZE, BY PATCH, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS SURGICAL GLUE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS SURGICAL GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS SURGICAL GLUE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY PATCH, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY PATCH, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLUE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLUE MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLUE MARKET SIZE, BY PATCH, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLUE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLUE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE SURGICAL GLUE MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE SURGICAL GLUE MARKET SIZE, BY PATCH, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE SURGICAL GLUE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE SURGICAL GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE SURGICAL GLUE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST SURGICAL GLUE MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST SURGICAL GLUE MARKET SIZE, BY PATCH, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST SURGICAL GLUE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST SURGICAL GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST SURGICAL GLUE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA SURGICAL GLUE MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA SURGICAL GLUE MARKET SIZE, BY PATCH, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA SURGICAL GLUE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA SURGICAL GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA SURGICAL GLUE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC SURGICAL GLUE MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC SURGICAL GLUE MARKET SIZE, BY PATCH, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC SURGICAL GLUE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC SURGICAL GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC SURGICAL GLUE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 251. GLOBAL SURGICAL GLUE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN SURGICAL GLUE MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN SURGICAL GLUE MARKET SIZE, BY PATCH, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN SURGICAL GLUE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN SURGICAL GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN SURGICAL GLUE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 268. GCC SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 269. GCC SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. GCC SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 271. GCC SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 272. GCC SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 273. GCC SURGICAL GLUE MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 274. GCC SURGICAL GLUE MARKET SIZE, BY PATCH, 2018-2032 (USD MILLION)
  • TABLE 275. GCC SURGICAL GLUE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 276. GCC SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. GCC SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 278. GCC SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 279. GCC SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 280. GCC SURGICAL GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 281. GCC SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 282. GCC SURGICAL GLUE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 283. GCC SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION SURGICAL GLUE MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION SURGICAL GLUE MARKET SIZE, BY PATCH, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION SURGICAL GLUE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPEAN UNION SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 296. EUROPEAN UNION SURGICAL GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 298. EUROPEAN UNION SURGICAL GLUE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 301. BRICS SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. BRICS SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 303. BRICS SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 304. BRICS SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 305. BRICS SURGICAL GLUE MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 306. BRICS SURGICAL GLUE MARKET SIZE, BY PATCH, 2018-2032 (USD MILLION)
  • TABLE 307. BRICS SURGICAL GLUE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 308. BRICS SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 309. BRICS SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 310. BRICS SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 311. BRICS SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 312. BRICS SURGICAL GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 313. BRICS SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 314. BRICS SURGICAL GLUE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 315. BRICS SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 316. G7 SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 317. G7 SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 318. G7 SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 319. G7 SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 320. G7 SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 321. G7 SURGICAL GLUE MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 322. G7 SURGICAL GLUE MARKET SIZE, BY PATCH, 2018-2032 (USD MILLION)
  • TABLE 323. G7 SURGICAL GLUE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 324. G7 SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 325. G7 SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 326. G7 SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 327. G7 SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 328. G7 SURGICAL GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 329. G7 SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 330. G7 SURGICAL GLUE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 331. G7 SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 332. NATO SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 333. NATO SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 334. NATO SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 335. NATO SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 336. NATO SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 337. NATO SURGICAL GLUE MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 338. NATO SURGICAL GLUE MARKET SIZE, BY PATCH, 2018-2032 (USD MILLION)
  • TABLE 339. NATO SURGICAL GLUE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 340. NATO SURGICAL GLUE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 341. NATO SURGICAL GLUE MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2032 (USD MILLION)
  • TABLE 342. NATO SURGICAL GLUE MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 343. NATO SURGICAL GLUE MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 344. NATO SURGICAL GLUE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 345. NATO SURGICAL GLUE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2032 (USD MILLION)
  • TABLE 346. NATO SURGICAL GLUE MARKET SIZE, BY CLINIC, 2018-2032 (USD MILLION)
  • TABLE 347. NATO SURGICAL GLUE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 348. GLOBAL SURGICAL GLUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 349. UNITED STATES SURGICAL GLUE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 350. UNITED STATES SURGICAL GLUE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 351. UNITED STATES SURGICAL GLUE MARKET SIZE, BY BIOLOGICAL ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 352. UNITED STATES SURGICAL GLUE MARKET SIZE, BY SYNTHETIC ADHESIVE, 2018-2032 (USD MILLION)
  • TABLE 353. UNITED STATES SURGICAL GLUE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 354. UNITED STATES SURGICAL GLUE MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 355. UNITED STATES SURGICAL GLUE MARKET SIZE, BY PATCH, 2018-2032 (USD MILLION)
  • TABLE 356. UNITED STATES SURGICAL GLUE MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)

TABLE 3